Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 543896

Role of H. pylori eradication therapy success on five year dynamics of dysplasia


Filipec Kanizaj, Tajana; Katicic, Miroslava; Skurla, Bruno; Prskalo, Marija; Colic Cvrlje, Vesna; Naumovski Mihalic, Slavica; Mrzljak, Anna; Bradic, Tihomir; Sobocan, Nikola
Role of H. pylori eradication therapy success on five year dynamics of dysplasia // Helicobacter, 16, Suppl 1 / David Y Graham (ur.).
Cambridge: John Wiley & Sons, 2011. str. 80-80 (predavanje, međunarodna recenzija, sažetak, znanstveni)


CROSBI ID: 543896 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Role of H. pylori eradication therapy success on five year dynamics of dysplasia

Autori
Filipec Kanizaj, Tajana ; Katicic, Miroslava ; Skurla, Bruno ; Prskalo, Marija ; Colic Cvrlje, Vesna ; Naumovski Mihalic, Slavica ; Mrzljak, Anna ; Bradic, Tihomir ; Sobocan, Nikola

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
Helicobacter, 16, Suppl 1 / David Y Graham - Cambridge : John Wiley & Sons, 2011, 80-80

Skup
24 International Workshop on Helicobacter and Related Bacteria in Chronic Digestive Inflammation and Gastric Cancer

Mjesto i datum
Dublin, Irska, 11.09.2011. - 13.09.2011

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
dysplasia; eradication therapy; H. pylori

Sažetak
Aim: to investigate the role of eradication therapy success on five year dynamics of dysplasia. Materials and methods: study was performed on 41 H. pylori positive patients with dysplasia in basic bioptic specimens analyzed according to updated Sydney protocol. All patients received triple eradication therapy. Therapy success and dynamics of dysplasia were evaluated according to 5th year histological finding. Results: basically 41 patients had dysplasia in corpus and/or antrum. Grade I 7, 31%, grade II 39, 02% and grade III 53, 65% of patients. H. pylori was successfully eradicated in 37 patients (90, 24%). In successfully eradicated, complete regression of dysplastic changes appeared in 33/37 (90, 89%) of patients. In all of rest 3 eradicated patients regression of grade of dysplasia was observed. In 2 of 4 non- eradicated patients complete regression of dysplasia and for rest 2 only regression of grade of dysplasia appeared. Statistically significant dynamics of grade of dysplasia was observed for successfully eradicated patients (Wilcox rank sum test, p<0, 001). The difference in proportion of patients with complete regression of dysplasia between eradicated and non - eradicated is statistically significant. Conclusions: In five year interval, proportion of patents with complete regression of dysplasia is statistically significantly higher in successfully eradicated patients than non- eradicated. In both groups regression of grade of dysplasia (and no progression) was observed with application of eradication therapy.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
108-0000000-3114 - HELICOBAKTER PYLORI INFEKCIJA - EVOLUCIJA BOLESTI I NOVI TERAPIJSKI POSTUPCI (Katičić, Miroslava, MZOS ) ( CroRIS)
108-1081873-1893 - Prognostički faktori, dijagnostika i terapija hemoblastoza (Jakšić, Branimir, MZOS ) ( CroRIS)

Ustanove:
Klinička bolnica "Merkur",
Medicinski fakultet, Zagreb


Citiraj ovu publikaciju:

Filipec Kanizaj, Tajana; Katicic, Miroslava; Skurla, Bruno; Prskalo, Marija; Colic Cvrlje, Vesna; Naumovski Mihalic, Slavica; Mrzljak, Anna; Bradic, Tihomir; Sobocan, Nikola
Role of H. pylori eradication therapy success on five year dynamics of dysplasia // Helicobacter, 16, Suppl 1 / David Y Graham (ur.).
Cambridge: John Wiley & Sons, 2011. str. 80-80 (predavanje, međunarodna recenzija, sažetak, znanstveni)
Filipec Kanizaj, T., Katicic, M., Skurla, B., Prskalo, M., Colic Cvrlje, V., Naumovski Mihalic, S., Mrzljak, A., Bradic, T. & Sobocan, N. (2011) Role of H. pylori eradication therapy success on five year dynamics of dysplasia. U: David Y Graham (ur.)Helicobacter, 16, Suppl 1.
@article{article, author = {Filipec Kanizaj, Tajana and Katicic, Miroslava and Skurla, Bruno and Prskalo, Marija and Colic Cvrlje, Vesna and Naumovski Mihalic, Slavica and Mrzljak, Anna and Bradic, Tihomir and Sobocan, Nikola}, year = {2011}, pages = {80-80}, keywords = {dysplasia, eradication therapy, H. pylori}, title = {Role of H. pylori eradication therapy success on five year dynamics of dysplasia}, keyword = {dysplasia, eradication therapy, H. pylori}, publisher = {John Wiley and Sons}, publisherplace = {Dublin, Irska} }
@article{article, author = {Filipec Kanizaj, Tajana and Katicic, Miroslava and Skurla, Bruno and Prskalo, Marija and Colic Cvrlje, Vesna and Naumovski Mihalic, Slavica and Mrzljak, Anna and Bradic, Tihomir and Sobocan, Nikola}, year = {2011}, pages = {80-80}, keywords = {dysplasia, eradication therapy, H. pylori}, title = {Role of H. pylori eradication therapy success on five year dynamics of dysplasia}, keyword = {dysplasia, eradication therapy, H. pylori}, publisher = {John Wiley and Sons}, publisherplace = {Dublin, Irska} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font